Belpointe Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-100
Closed -$1.18K 3093
2023
Q1
$1.18K Buy
+100
New +$1.18K ﹤0.01% 3445